PURPOSE: To determine whether performing near activities while patching for amblyopia enhances improvement in visual acuity. DESIGN: Randomized clinical trial. PARTICIPANTS: A total of 425 children, aged 3 to <7 years, with amblyopia (20/40-20/400) that was caused by anisometropia, strabismus, or both, and that persisted after treatment with spectacles. METHODS: Children were randomized to 2 hours of patching per day with near activities or 2 hours of patching per day with distance activities. Instruction sheets describing common near and distance activities were given to the parents. Study visits were scheduled at 2, 5, 8, and 17 weeks. In weeks without a visit, weekly telephone calls were made to the parent to monitor and encourage compliance during the first 8 weeks. MAIN OUTCOME MEASURE: Masked assessment of visual acuity by isolated crowded HOTV optotypes at 8 weeks. RESULTS: At 8 weeks, improvement in amblyopic eye visual acuity averaged 2.6 lines in the distance activities group and 2.5 lines in the near activities group (mean difference in acuity between groups, adjusted for baseline acuity, 0.0 lines 95% confidence interval, -0.3 to 0.3). The 2 groups also appeared statistically similar at the 2-, 5-, and 17-week visits. At the 17-week examination, children with severe amblyopia improved a mean of 3.6 lines with 2 hours of daily patching. CONCLUSIONS: Performing common near activities does not improve visual acuity outcome when treating anisometropic, strabismic, or combined amblyopia with 2 hours of daily patching. Children with severe amblyopia may respond to 2 hours of daily patching.
RCT Entities:
PURPOSE: To determine whether performing near activities while patching for amblyopia enhances improvement in visual acuity. DESIGN: Randomized clinical trial. PARTICIPANTS: A total of 425 children, aged 3 to <7 years, with amblyopia (20/40-20/400) that was caused by anisometropia, strabismus, or both, and that persisted after treatment with spectacles. METHODS:Children were randomized to 2 hours of patching per day with near activities or 2 hours of patching per day with distance activities. Instruction sheets describing common near and distance activities were given to the parents. Study visits were scheduled at 2, 5, 8, and 17 weeks. In weeks without a visit, weekly telephone calls were made to the parent to monitor and encourage compliance during the first 8 weeks. MAIN OUTCOME MEASURE: Masked assessment of visual acuity by isolated crowded HOTV optotypes at 8 weeks. RESULTS: At 8 weeks, improvement in amblyopic eye visual acuity averaged 2.6 lines in the distance activities group and 2.5 lines in the near activities group (mean difference in acuity between groups, adjusted for baseline acuity, 0.0 lines 95% confidence interval, -0.3 to 0.3). The 2 groups also appeared statistically similar at the 2-, 5-, and 17-week visits. At the 17-week examination, children with severe amblyopia improved a mean of 3.6 lines with 2 hours of daily patching. CONCLUSIONS: Performing common near activities does not improve visual acuity outcome when treating anisometropic, strabismic, or combined amblyopia with 2 hours of daily patching. Children with severe amblyopia may respond to 2 hours of daily patching.
Authors: P S Moke; A H Turpin; R W Beck; J M Holmes; M X Repka; E E Birch; R W Hertle; R T Kraker; J M Miller; C A Johnson Journal: Am J Ophthalmol Date: 2001-12 Impact factor: 5.258
Authors: J M Holmes; R W Beck; M X Repka; D A Leske; R T Kraker; R C Blair; P S Moke; E E Birch; R A Saunders; R W Hertle; G E Quinn; K A Simons; J M Miller Journal: Arch Ophthalmol Date: 2001-09
Authors: Susan A Cotter; Allison R Edwards; David K Wallace; Roy W Beck; Robert W Arnold; William F Astle; Carmen N Barnhardt; Eileen E Birch; Sean P Donahue; Donald F Everett; Joost Felius; Jonathan M Holmes; Raymond T Kraker; Michele Melia; Michael X Repka; Nicholas A Sala; David I Silbert; Katherine K Weise Journal: Ophthalmology Date: 2006-06 Impact factor: 12.079
Authors: Jonathan M Holmes; Allison R Edwards; Roy W Beck; Robert W Arnold; David A Johnson; Deborah L Klimek; Raymond T Kraker; Katherine A Lee; Don W Lyon; Erin R Nosel; Michael X Repka; Nicholas A Sala; David I Silbert; Susanna Tamkins Journal: J AAPOS Date: 2005-04 Impact factor: 1.220
Authors: Jonathan M Holmes; Raymond T Kraker; Roy W Beck; Eileen E Birch; Susan A Cotter; Donald F Everett; Richard W Hertle; Graham E Quinn; Michael X Repka; Mitchell M Scheiman; David K Wallace Journal: Ophthalmology Date: 2003-11 Impact factor: 12.079
Authors: Michael X Repka; Roy W Beck; Jonathan M Holmes; Eileen E Birch; Danielle L Chandler; Susan A Cotter; Richard W Hertle; Raymond T Kraker; Pamela S Moke; Graham E Quinn; Mitchell M Scheiman Journal: Arch Ophthalmol Date: 2003-05
Authors: David K Wallace; Elizabeth L Lazar; Michele Melia; Eileen E Birch; Jonathan M Holmes; Kristine B Hopkins; Raymond T Kraker; Marjean T Kulp; Yi Pang; Michael X Repka; Susanna M Tamkins; Katherine K Weise Journal: J AAPOS Date: 2011-10 Impact factor: 1.220
Authors: Jonathan M Holmes; Elizabeth L Lazar; B Michele Melia; William F Astle; Linda R Dagi; Sean P Donahue; Marcela G Frazier; Richard W Hertle; Michael X Repka; Graham E Quinn; Katherine K Weise Journal: Arch Ophthalmol Date: 2011-07-11
Authors: David K Wallace; Elizabeth L Lazar; Earl R Crouch; Darren L Hoover; Raymond T Kraker; Susanna M Tamkins Journal: JAMA Ophthalmol Date: 2015-05 Impact factor: 7.389
Authors: Jonathan M Holmes; Ruth E Manny; Elizabeth L Lazar; Eileen E Birch; Krista R Kelly; Allison I Summers; Stacy R Martinson; Aparna Raghuram; Jeffrey D Colburn; Christine Law; Justin D Marsh; Derek P Bitner; Raymond T Kraker; David K Wallace Journal: Ophthalmology Date: 2018-10-22 Impact factor: 12.079
Authors: David K Wallace; Elizabeth L Lazar; Jonathan M Holmes; Michael X Repka; Susan A Cotter; Angela M Chen; Raymond T Kraker; Roy W Beck; Michael P Clarke; Ingryd J Lorenzana; David B Petersen; Joan T Roberts; Donny W Suh Journal: Ophthalmology Date: 2013-06-04 Impact factor: 12.079
Authors: Jonathan M Holmes; Vivian M Manh; Elizabeth L Lazar; Roy W Beck; Eileen E Birch; Raymond T Kraker; Eric R Crouch; S Ayse Erzurum; Nausheen Khuddus; Allison I Summers; David K Wallace Journal: JAMA Ophthalmol Date: 2016-12-01 Impact factor: 7.389